✦ LIBER ✦

Double-Blind Study of Prazepam in the Treatment of Anxiety

✍ Scribed by Dunlop, Edwin; Weisberg, Jerry

Book ID: 122001593
Publisher: American Psychiatric Publishing Inc
Year: 1968
Tongue: English
Weight: 462 KB
Volume: 9
Category: Article
ISSN: 1545-7206
DOI: 10.1016/S0033-3182(68)71849-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind study of Prazepam versus

A double-blind study of Prazepam versus placebo in single daily doses in the treatment of anxiety

✍ H.L. Goldberg; R.J. Finnerty 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Etizolam in the treatment of generalized

Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo

✍ Casacchia, Massimo; Bolino, Francesca; Ecari, Ugo 📂 Article 📅 1990 🏛 Informa plc 🌐 English ⚖ 552 KB

Randomized comparison of atenolol and pl

Randomized comparison of atenolol and placebo in the treatment of anxiety: A double-blind study

✍ P. Saul; B. P. Jones; K. G. Edwards; J. A. Tweed 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 160 KB

Ranitidine versus ranitidine and prazepa

Ranitidine versus ranitidine and prazepam in the short-term treatment of duodenal ulcer — a double-blind controlled trial

✍ C. Hüscher; G. Magni; A. Salmi; S. Bossini; C. Felini; F. Besozzi; D. Leo 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 370 KB

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Alprazolam in the treatment of generaliz

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage